Lobbying Information
Subject Matters
- Health
- Science and Technology
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Obtain financial support from the Federal Government regarding research and development activities
Policies or Program
- Advocacy to maintain and increase funding for the National Immunization Strategy.
- Discussions on Canada’s procurement policies related to vaccines, in particular as it relates to Medicago’s COVID-19 vaccine candidate.
- To actively promote the value of the pharmaceutical industry for Canada's economy, including through policies that will attract increased investment in the pharmaceutical industry.
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
Government Institutions
-
Canada Economic Development for Quebec Regions
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Prime Minister's Office (PMO)
-
Senate of Canada
Government institutions added through a monthly communication report
- Public Health Agency of Canada (PHAC)
In-house Corporation Details
Description of activities
Medicago is a pioneer and global leader in developing and producing plant-based vaccines and therapeutics. Medicago’s unique technology harnesses the natural processes of living plants to help respond to new global health challenges.
Responsible officer name and position during the period of this registration
Takashi Nagao,
President and Chief Executive Officer
Government funding
End date of the last completed financial year:
2021-03-31
List of Government Funding
|
Government Institution
|
Funding Received in Last Financial Year
|
Funding Expected in Current Financial Year
|
|
Innovation, Science and Economic Development Canada (ISED)
|
$21,075,000.00
|
Yes
|
|
Investissement Quebec
|
$7,000,000.00
|
No
|
|
National Research Council (NRC)
|
$270,199.45
|
Yes
|
In-house Corporation Contact Information
Address:
1020 route de l'Eglise, Suite 600
Quebec, QC G1V 3V9
Canada
Telephone number:
418-658-9393
Parent Company Information
- Mitsubishi Tanabe Pharma Corporation
-
2-10, Dosho-machi 3-chome, Chuo-ku
Osaka 541-8505
Japan
Subsidiary Beneficiary Information
- Medicago R&D Inc
-
1020 route de l'Eglise, Suite 600
Quebec, QC G1V 3V9
Canada
- Medicago USA
-
7 Triangle Drive
Durham, NC 27713
United States of America
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Takashi Nagao,
President and Chief Executive Officer |
No public offices held
- Nicolas Petit,
Vice President, Commercial Operations |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
No lobbyists added
